- Home
- ENTX vs ZENV Comparison
ENTX vs ZENV Comparison
Compare ENTX & ZENV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENTX
- ZENV
- Stock Information
- Founded
- ENTX 2010
- ZENV 2005
- Country
- ENTX Israel
- ZENV Brazil
- Employees
- ENTX N/A
- ZENV N/A
- Industry
- ENTX Biotechnology: Biological Products (No Diagnostic Substances)
- ZENV Computer Software: Prepackaged Software
- Sector
- ENTX Health Care
- ZENV Technology
- Exchange
- ENTX Nasdaq
- ZENV Nasdaq
- Market Cap
- ENTX 67.2M
- ZENV 63.3M
- IPO Year
- ENTX 2018
- ZENV 2021
- Fundamental
- Price
- ENTX $2.25
- ZENV $1.76
- Analyst Decision
- ENTX Strong Buy
- ZENV
- Analyst Count
- ENTX 1
- ZENV 0
- Target Price
- ENTX $10.00
- ZENV N/A
- AVG Volume (30 Days)
- ENTX 54.3K
- ZENV 105.4K
- Earning Date
- ENTX 11-08-2024
- ZENV 11-18-2024
- Dividend Yield
- ENTX N/A
- ZENV N/A
- EPS Growth
- ENTX N/A
- ZENV N/A
- EPS
- ENTX N/A
- ZENV N/A
- Revenue
- ENTX $99,000.00
- ZENV $173,594,726.00
- Revenue This Year
- ENTX N/A
- ZENV $25.56
- Revenue Next Year
- ENTX N/A
- ZENV $6.02
- P/E Ratio
- ENTX N/A
- ZENV N/A
- Revenue Growth
- ENTX 607.14
- ZENV 23.49
- 52 Week Low
- ENTX $0.52
- ZENV $1.00
- 52 Week High
- ENTX $3.35
- ZENV $3.88
- Technical
- Relative Strength Index (RSI)
- ENTX 68.35
- ZENV 62.77
- Support Level
- ENTX $2.02
- ZENV $1.61
- Resistance Level
- ENTX $2.28
- ZENV $1.76
- Average True Range (ATR)
- ENTX 0.17
- ZENV 0.12
- MACD
- ENTX 0.04
- ZENV 0.01
- Stochastic Oscillator
- ENTX 77.01
- ZENV 66.67
About ENTX Entera Bio Ltd.
Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins. The company focuses on underserved, chronic medical conditions where oral administration of a mini tablet peptide or peptide replacement therapy has the potential to significantly shift a treatment paradigm. Its product candidates are; EB613 for the treatment of osteoporosis and EB612 for the treatment of hypoparathyroidism are first-in-class mini tablet formulations of synthetic human PTH (1-34) (teriparatide), designed to have differing pharmacokinetic, or PK, profiles.
About ZENV Zenvia Inc.
Zenvia Inc provides a platform that enables companies to create unique journeys for their end customers across a variety of channels. The company operates in two reportable segments namely CPaaS and SaaS. It has a geographic presence in Brazil, the USA, Argentina, Mexico, and Others. The company generates the majority of its revenue from Brazil.